PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,271,000 | -77.0% | 121,876 | +1.0% | 0.00% | -77.8% |
| Q3 2018 | $5,531,000 | -18.5% | 120,640 | +0.2% | 0.01% | -25.0% |
| Q2 2018 | $6,788,000 | -71.1% | 120,457 | -65.1% | 0.01% | -70.7% |
| Q1 2018 | $23,475,000 | -30.5% | 344,965 | +0.9% | 0.04% | -25.5% |
| Q4 2017 | $33,786,000 | -16.8% | 341,790 | -1.3% | 0.06% | -22.5% |
| Q3 2017 | $40,629,000 | +23.3% | 346,369 | -8.8% | 0.07% | +20.3% |
| Q2 2017 | $32,942,000 | -45.4% | 379,734 | -76.4% | 0.06% | +9.3% |
| Q1 2017 | $60,294,000 | +200.0% | 1,607,852 | +145.6% | 0.05% | +42.1% |
| Q4 2016 | $20,100,000 | – | 654,721 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |